Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study-Reference-Cited by-同舟云学术

Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study

Published:2021-01-27 Issue:3 Volume:14 Page:1002-1014
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Sato Tsugumichi¹,Cheng Ching‐Lan²³,Park Heung‐Woo⁴,Kao Yang Yea‐Huei²,Yang Min‐Suk⁵,Fujita Mizuki¹,Kumagai Yuji⁶,Tohkin Masahiro⁷,Saito Yoshiro⁸,Sai Kimie⁸

Affiliation:

1. Department of Pharmacy Faculty of Pharmaceutical Sciences Tokyo University of Science Tokyo Japan

2. School of Pharmacy Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine National Cheng Kung University Tainan Taiwan

3. Department of Pharmacy National Cheng Kung University Hospital College of Medicine National Cheng Kung University Tainan Taiwan

4. Department of Internal Medicine Seoul National University College of Medicine Seoul Korea

5. Department of Internal Medicine SMG‐SNU Boramae Medical Center Seoul Korea

6. Clinical Research Center School of Medicine Kitasato University Tokyo Japan

7. Department of Regulatory Science Graduate School of Pharmaceutical Science Nagoya City University Nagoya Japan

8. Division of Medicinal Safety Science National Institute of Health Sciences Kawasaki Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12964

Reference44 articles.

1. Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development

2. Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice

3. A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations

4. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.Ethnic factors in the acceptability a foreign clinical data E5 (R1).https://database.ich.org/sites/default/files/E5_R1__Guideline.pdf. c1998. Accessed February 5 1998.

5. Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study;Drug Safety;2024-02-14

2. The Evolving Landscape of Gout in the Female: A Narrative Review;Gout, Urate, and Crystal Deposition Disease;2023-12-30

3. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review;Drugs;2023-10-11

4. Real-world treatment of gout and asymptomatic hyperuricaemia in Japan;Modern Rheumatology;2023-01-20

5. Genetic associations of human leukocyte antigen alleles in cutaneous delayed drug hypersensitivity reactions: An updated review;Dermatologica Sinica;2023